ArticleOPEN ACCESS

Erdheim-Chester disease: The “targeted” revolution

Blood
DOI: 10.1182/blood-2017-07-795054
12Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Cohen Aubart et al present a large series of patients with Erdheim-Chester disease (ECD) treated with BRAF and MEK inhibitors and describe the disease trajectory in a subset of these patients after treatment withdrawal.1

Cite

CITATION STYLE

APA

Vaglio, A., & Diamond, E. L. (2017, September 14). Erdheim-Chester disease: The “targeted” revolution. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-07-795054

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free